====== THZ1 0.06μM R08 exp531 ======
==== Mechanism of Action ====
Inhibits CDK7, forms covalent adduct, blocks phosphorylation of the C-terminal domain of RNA polymerase II
* **Class / Subclass 1:** Gene Regulation / Transcription Inhibitor
* **Class / Subclass 2:** Signal Transduction / Kinase Inhibitor
==== Technical Notes ====
* **PubChem Name:** %%THZ1 Hydrochloride%%
* **Synonyms:** N/A
* **CAS #:** N/A
* **PubChem CID:** [[https://pubchem.ncbi.nlm.nih.gov/compound/78358326|78358326]]
* **IUPAC:** %%N-[3-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]phenyl]-4-[[(E)-4-(dimethylamino)but-2-enoyl]amino]benzamide;hydrochloride%%
* **INCHI Name:** InChI=1S/C31H28ClN7O2.ClH/c1-39(2)16-6-11-28(40)35-21-14-12-20(13-15-21)30(41)36-22-7-5-8-23(17-22)37-31-34-19-26(32)29(38-31)25-18-33-27-10-4-3-9-24(25)27;/h3-15,17-19,33H,16H2,1-2H3,(H,35,40)(H,36,41)(H,34,37,38);1H/b11-6+;
* **INCHI Key:** LSAGMHUBJCPLJS-ICSBZGNSSA-N
* **Molecular Weight:** 602.5
* **Canonical SMILES:** CN(C)CC=CC(=O)NC1=CC=C(C=C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)C4=CNC5=CC=CC=C54)Cl.Cl
* **Isomeric SMILES:** CN(C)C/C=C/C(=O)NC1=CC=C(C=C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)C4=CNC5=CC=CC=C54)Cl.Cl
* **Molecular Formula:** C31H29Cl2N7O2
{{:chemogenomics:structures:chem-0335.svg?nolink}}
* **Supplier Name:** Med Chem Express
* **Catalog #:** HY-80013A
* **Lot #:** 25842
* **HRMS (ESI-TOF) m/z:** (M+H)+ Calcd for C31H28ClN7O2 566.20658; found 566.20799
* **Platform ID:** THZ1
* **Min:** -3.2339; **Max:** 99.8907
{{:chemogenomics:dose_response:dr_588.png?nolink&500 |}}
\\
\\
\\
\\
|< 300px 100px 200px >|
^ IC ^ Concentration (µM) ^
| IC10 |0.0053 |
| IC20 |0.0131 |
| IC30 |0.0240 |
| IC40 |0.0394 |
| IC50 |0.0622 |
| IC60 |0.0981 |
| IC70 |0.1612 |
| IC80 |0.2954 |
| IC90 |0.7349 |
\\
==== Screen Summary ====
* **Round**: 08
* **Dose**: 60nM
* **Days of incubation**: 8
* **Doublings**: -0.3
* **Numbers of reads**: 16956922
==== Screen Results ====
^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^
|0/42|[[https://files.tyerslab.com/files/public/chemogenomics/cranks/THZ1_0.06uM_Round-8_exp531.txt|Scores]]||||||
{{:chemogenomics:cranks_plots:exp531.png?nolink}}
^Gene^CRANKS Score^FDR^
|[[:human_genes:W:WDR61|WDR61]]|-2.73|0.28|
|[[:human_genes:P:POLD2|POLD2]]|-2.69|0.28|
|[[:human_genes:F:FANCI|FANCI]]|-2.63|0.28|
|[[:human_genes:G:GOLGA6L1|GOLGA6L1]]|-2.56|0.53|
|[[:human_genes:N:NCLN|NCLN]]|-2.54|0.28|
|[[:human_genes:P:PSMA1|PSMA1]]|-2.45|0.29|
|[[:human_genes:E:EXOSC4|EXOSC4]]|-2.40|0.29|
|[[:human_genes:A:ATP6V1A|ATP6V1A]]|-2.34|0.29|
|[[:human_genes:U:UBA1|UBA1]]|-2.34|0.52|
|[[:human_genes:S:SPI1|SPI1]]|-2.34|0.28|
|[[:human_genes:R:RPS9|RPS9]]|-2.28|0.53|
|[[:human_genes:H:HIST1H4E|HIST1H4E]]|-2.26|0.28|
|[[:human_genes:T:TAF9|TAF9]]|-2.24|0.28|
|[[:human_genes:A:ABCA13|ABCA13]]|-2.23|0.29|
|[[:human_genes:F:FAM186A|FAM186A]]|-2.21|0.29|
|[[:human_genes:C:CFLAR|CFLAR]]|-2.20|0.28|
|[[:human_genes:C:CMC2|CMC2]]|-2.18|0.51|
|[[:human_genes:C:CDC73|CDC73]]|-2.17|0.36|
|[[:human_genes:Z:ZNF121|ZNF121]]|-2.17|0.28|
|[[:human_genes:C:CHD8|CHD8]]|-2.16|0.28|
|[[:human_genes:B:BCOR|BCOR]]|-2.15|0.28|
|[[:human_genes:F:FADS6|FADS6]]|-2.14|0.39|
|[[:human_genes:C:CDCA8|CDCA8]]|-2.14|0.51|
|[[:human_genes:T:TRIM36|TRIM36]]|-2.12|0.29|
|[[:human_genes:T:TAS2R60|TAS2R60]]|-2.09|0.29|
|[[:human_genes:U:UBXN1|UBXN1]]|-2.08|0.41|
|[[:human_genes:P:PASD1|PASD1]]|-2.08|0.29|
|[[:human_genes:F:FPR2|FPR2]]|-2.06|0.36|
|[[:human_genes:S:SART1|SART1]]|-2.06|0.53|
|[[:human_genes:I:IL12A|IL12A]]|-2.06|0.29|
|[[:human_genes:A:ATP5B|ATP5B]]|2.51|0.01|
|[[:human_genes:T:TAZ|TAZ]]|2.51|0.15|
|[[:human_genes:C:CDH22|CDH22]]|2.52|0.02|
|[[:human_genes:P:PARL|PARL]]|2.56|0.02|
|[[:human_genes:T:THG1L|THG1L]]|2.60|0.01|
|[[:human_genes:D:DOHH|DOHH]]|2.60|0.02|
|[[:human_genes:M:MARCH5|MARCH5]]|2.60|0.02|
|[[:human_genes:C:C10orf12|C10orf12]]|2.64|0.02|
|[[:human_genes:M:MLST8|MLST8]]|2.70|<0.01|
|[[:human_genes:T:TTI2|TTI2]]|2.73|0.01|
|[[:human_genes:H:HSPD1|HSPD1]]|2.74|<0.01|
|[[:human_genes:T:TP53|TP53]]|2.84|<0.01|
|[[:human_genes:T:TTI1|TTI1]]|2.84|<0.01|
|[[:human_genes:G:GNB1L|GNB1L]]|2.87|<0.01|
|[[:human_genes:F:FBXO11|FBXO11]]|2.88|<0.01|
|[[:human_genes:M:MED23|MED23]]|2.88|<0.01|
|[[:human_genes:C:CASP9|CASP9]]|2.97|<0.01|
|[[:human_genes:V:VDAC2|VDAC2]]|3.13|<0.01|
|[[:human_genes:A:ALAS1|ALAS1]]|3.13|0.01|
|[[:human_genes:M:MTOR|MTOR]]|3.15|<0.01|
|[[:human_genes:K:KMT2D|KMT2D]]|3.16|<0.01|
|[[:human_genes:R:RPTOR|RPTOR]]|3.17|<0.01|
|[[:human_genes:T:TELO2|TELO2]]|3.26|<0.01|
|[[:human_genes:C:CYCS|CYCS]]|3.41|<0.01|
|[[:human_genes:A:ATP5J|ATP5J]]|3.53|<0.01|
|[[:human_genes:H:HCCS|HCCS]]|3.94|<0.01|
|[[:human_genes:A:APAF1|APAF1]]|4.18|<0.01|
|[[:human_genes:G:GMPPB|GMPPB]]|4.74|<0.01|
|[[:human_genes:B:BAK1|BAK1]]|5.68|<0.01|
|[[:human_genes:B:BEND3|BEND3]]|7.22|<0.01|
^Screen^Correlation^Plot^
|[[:results:exp527|Tanespimycin 14μM R08 exp527]]|0.089||
|[[:results:exp532|TIC10 10μM R08 exp532]]|0.06||
|[[:results:exp106|UM131593 0.2μM R03 exp106]]|0.053||
|[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|0.052||
|[[:results:exp478|Doxorubicin 0.02μM R08 exp478]]|0.146||
|[[:results:exp443|SNS-032 15μM R08 exp443]]|0.146||
|[[:results:exp459|Bleomycin 5μM R08 exp459]]|0.142||
|[[:results:exp456|Benzoate 20000μM R08 exp456]]|0.136||
|[[:results:exp2|5-Fluorouracil 20μM R00 exp2]]|0.128||
|[[:results:exp28|Pimelic-diphenylamide-106 5μM R00 exp28]]|0.124||
|[[:results:exp503|Mitomycin-C 0.06μM R08 exp503]]|0.12||
|[[:results:exp472|CI-1040 9.5μM R08 exp472]]|0.112||
|[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|0.106||
|[[:results:exp199|Etoposide 0.3μM R05 exp199]]|0.103||
|[[:results:exp451|Atovaquone 15μM R08 exp451]]|0.099||
|[[:results:exp259|6-Thio-2-deoxyguanosine 2μM R06 exp259]]|0.096||
|[[:results:exp22|MLN-4924 2μM R00 exp22]]|0.096||
|[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|0.095||
|[[:results:exp135|MS023 7μM R03 exp135]]|0.094||
|[[:results:exp80|RO-3307 4.7μM R02 exp80]]|0.093||
|[[:results:exp34|Rotenone 20μM R00 exp34]]|0.093||
|[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|0.093||
|[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|0.091||
|[[:results:exp211|AICAR 240μM R05 exp211]]|0.09||
|[[:results:exp515|PU-H71 1μM R08 exp515]]|0.089||
|[[:results:exp435|JQ1 0.8μM R08 exp435]]|0.086||
|[[:results:exp19|Etoposide 1μM R00 exp19]]|0.081||
|[[:results:exp96|BI-2536 0.02μM R03 exp96]]|0.078||
|[[:results:exp474|CR131-b 0.005μM R08 exp474]]|0.077||
|[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|0.077||
|[[:results:exp487|Hinokiflavone 12μM R08 exp487]]|0.075||
|[[:results:exp17|DABN 20μM R00 exp17]]|0.074||
|[[:results:exp512|Olaparib 4μM R08 exp512]]|0.074||
|[[:results:exp134|MS023 2μM R03 exp134]]|0.064||
|[[:results:exp448|Ammonium tetrathiomolybdate 10μM R08 exp448]]|0.062||
|[[:results:exp126|GSK461364A 0.1μM R03 exp126]]|0.062||
|[[:results:exp98|BI-6727 0.04μM R03 exp98]]|0.062||
|[[:results:exp485|GSK626616 14μM R08 exp485]]|0.061||
|[[:results:exp539|42°C R08 exp539]]|0.059||
|[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|0.057||
|[[:results:exp441|GSK-J4 1.5μM R08 exp441]]|0.057||
|[[:results:exp517|Quercetin 20μM R08 exp517]]|0.055||
|[[:results:exp93|DABN racemic mixture R03 exp93]]|0.053||
|[[:results:exp357|Dorsomorphin 5μM R07 exp357]]|0.052||
{{:chemogenomics:comparison_plots:exp527_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp531_vs_exp532.png?nolink |}}
{{:chemogenomics:comparison_plots:exp106_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp529_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp478_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp443_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp459_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp456_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp2_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp28_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp503_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp472_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp3_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp199_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp451_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp259_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp22_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp440_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp135_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp531_vs_exp80.png?nolink |}}
{{:chemogenomics:comparison_plots:exp34_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp488_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp489_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp515_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp435_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp19_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp531_vs_exp96.png?nolink |}}
{{:chemogenomics:comparison_plots:exp474_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp524_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp487_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp17_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp512_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp134_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp448_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp126_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp531_vs_exp98.png?nolink |}}
{{:chemogenomics:comparison_plots:exp485_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp531_vs_exp539.png?nolink |}}
{{:chemogenomics:comparison_plots:exp500_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp441_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp517_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp531_vs_exp93.png?nolink |}}
{{:chemogenomics:comparison_plots:exp357_vs_exp531.png?nolink |}}
No GO term hits below threshold. (FDR <0.05)
^GO Term^Fold Change^Genes^
|apoptosome|552.30|APAF1,CASP9|
|positive regulation of pentose-phosphate shunt|552.30|RPTOR,MLST8|
|TTT complex|552.30|TELO2,TTI1|
|TORC1 complex|441.84|TELO2,MTOR,TTI1,MLST8|
|regulation of pentose-phosphate shunt|368.20|RPTOR,MTOR,TP53,MLST8|
|activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c|331.38|APAF1,CYCS,CASP9|
|regulation of NADP metabolic process|315.60|RPTOR,MTOR,TP53,MLST8|
|TOR complex|276.15|TELO2,RPTOR,MTOR,TTI1,MLST8|
|TORC2 complex|276.15|TELO2,MTOR,TTI1,MLST8|
|rDNA binding|165.69|BEND3,RPTOR,MTOR|
|TORC1 signaling|150.63|RPTOR,MTOR,MLST8|
|positive regulation of purine nucleotide metabolic process|129.95|BEND3,RPTOR,MTOR,MLST8|
|positive regulation of nucleotide metabolic process|129.95|BEND3,RPTOR,MTOR,MLST8|
|regulation of purine nucleotide metabolic process|65.75|BEND3,RPTOR,MTOR,TP53,MLST8|
|regulation of nucleotide metabolic process|64.22|BEND3,RPTOR,MTOR,TP53,MLST8|
|apoptotic mitochondrial changes|39.45|BAK1,VDAC2,TP53,HSPD1|
|positive regulation of cysteine-type endopeptidase activity|22.45|BAK1,APAF1,CYCS,CASP9,HSPD1|
|mitochondrial membrane|9.40|BAK1,HCCS,ATP5PF,CYCS,MTOR,ALAS1,VDAC2,HSPD1,MARCHF5,THG1L,PARL,ATP5F1B|
|mitochondrial envelope|8.83|BAK1,HCCS,ATP5PF,CYCS,MTOR,ALAS1,VDAC2,HSPD1,MARCHF5,THG1L,PARL,ATP5F1B|